Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wohlgemuth

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nature Structural Biology|September 26, 1997
Structure of the Ras-binding domain of RalGEF and implications for Ras binding and signallingM Geyer, C Herrmann, S Wohlgemuth, et al.
Journal of Molecular Biology|September 1, 2000
Structural consequences of mono-glucosylation of Ha-Ras by Clostridium sordellii lethal toxinI R Vetter, F Hofmann, S Wohlgemuth, et al.
The Journal of Cardiovascular Surgery|March 1, 1988
Early experience utilizing the in situ saphenous vein technique in 54 patientsE C Strayhorn, S Wohlgemuth, M Deuel, et al.
Journal of Biomolecular NMR|May 29, 2000
Sequential NMR assignment of the RAS-binding domain of Byr2F Huber, W Gronwald, S Wohlgemuth, et al.
Structure (London, England : 1993)|November 16, 2001
Solution structure of the Ras binding domain of the protein kinase Byr2 from Schizosaccharomyces pombeW Gronwald, F Huber, P Grünewald, et al.
FEBS Letters|June 17, 1999
Structural and biochemical analysis of Ras-effector signaling via RalGDSI R Vetter, T Linnemann, S Wohlgemuth, et al.
Structure (London, England : 1993)|November 16, 2001
The Ras-Byr2RBD complex: structural basis for Ras effector recognition in yeastK Scheffzek, P Grünewald, S Wohlgemuth, et al.
Inflammatory Bowel Diseases|July 30, 2009
Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel diseaseC Reiff, M Delday, G Rucklidge, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nature Structural Biology|September 26, 1997
Structure of the Ras-binding domain of RalGEF and implications for Ras binding and signallingM Geyer, C Herrmann, S Wohlgemuth, et al.
Journal of Molecular Biology|September 1, 2000
Structural consequences of mono-glucosylation of Ha-Ras by Clostridium sordellii lethal toxinI R Vetter, F Hofmann, S Wohlgemuth, et al.
The Journal of Cardiovascular Surgery|March 1, 1988
Early experience utilizing the in situ saphenous vein technique in 54 patientsE C Strayhorn, S Wohlgemuth, M Deuel, et al.
Journal of Biomolecular NMR|May 29, 2000
Sequential NMR assignment of the RAS-binding domain of Byr2F Huber, W Gronwald, S Wohlgemuth, et al.
Structure (London, England : 1993)|November 16, 2001
Solution structure of the Ras binding domain of the protein kinase Byr2 from Schizosaccharomyces pombeW Gronwald, F Huber, P Grünewald, et al.
FEBS Letters|June 17, 1999
Structural and biochemical analysis of Ras-effector signaling via RalGDSI R Vetter, T Linnemann, S Wohlgemuth, et al.
Structure (London, England : 1993)|November 16, 2001
The Ras-Byr2RBD complex: structural basis for Ras effector recognition in yeastK Scheffzek, P Grünewald, S Wohlgemuth, et al.
Inflammatory Bowel Diseases|July 30, 2009
Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel diseaseC Reiff, M Delday, G Rucklidge, et al.
Pageof 2